Skip to content
Insider tapeFilings through Fri, Oct 2
MRK

Merck & Co. insider trading

Health Care · Heavy selling
Close · Oct 5, 2026 $139.54 +61.8% over 12 months

Share price and insider trades

MRK closeInsider buyInsider sale
75100125150175NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $616,395 on 2025-11-10 · Cristal N DowningSold $720,040 on 2025-11-03 · David Michael WilliamsSold $1,202,844 on 2026-02-10 · Dean Y LiSold $1,214,562 on 2026-02-12 · Chirfi GuindoSold $1,350,000 on 2026-08-13 · Chirfi GuindoSold $1,691,426 on 2026-08-11 · Richard R. DelucaSold $2,437,676 on 2026-02-05 · Chirfi GuindoSold $2,710,951 on 2026-08-10 · Richard R. DelucaSold $2,753,773 on 2026-08-06 · Chirfi Guindo, Richard R. DelucaSold $6,994,541 on 2026-02-06 · David Michael Williams, Johannes Jacobus Oosthuizen, Richard R. DelucaSold $9,212,942 on 2026-08-05 · David Michael Williams, David R. MaraldoSold $12,258,487 on 2026-08-12 · Jennifer Zachary, Richard R. DelucaSold $13,180,383 on 2026-02-04 · Caroline Litchfield, Dalton E. Smart III, Dean Y Li, Robert M DavisSold $15,669,791 on 2026-02-09 · Chirfi Guindo, Jennifer Zachary
Bought, 12 months$0
Sold, 12 months$72.0M
Insiders buying0
Insiders selling11

Valuation, profit and volume

P/E (trailing)110.7Sector median 24.5
Market value$344.27BDrug Manufacturers - General
Profit margin4.8%Revenue growth +5.1%
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Merck & Co. insiders reported open-market purchases totaling $0, while 11 insiders reported sales totaling $72.0M. 0 of 35 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales. 56 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Aug 13SEC Jennifer ZacharyGeneral Counsel Sell 80,315 $133.46 $10.7M +4.6% —
Aug 13SEC Chirfi GuindoEvp, Access, Policy & Comms Sell 10,000 $135.00 $1.4M +3.4% —
Aug 12SEC Richard R. DelucaEvp&Pres, Merck Animal Heallth Sell 20,784 $130.43 $2.7M +7.0% —
Aug 12SEC Richard R. DelucaEvp&Pres, Merck Animal Heallth Sell 11,099 $131.61 $1.5M +6.0% —
Aug 12SEC Richard R. DelucaEvp&Pres, Merck Animal Heallth Sell 7,410 $131.33 $973K +6.3% —
Aug 12SEC Richard R. DelucaEvp&Pres, Merck Animal Heallth Sell 5,427 $132.35 $718K +5.4% —
Aug 12SEC Richard R. DelucaEvp&Pres, Merck Animal Heallth Sell 600 $132.04 $79K +5.7% —
Aug 10SEC Richard R. DelucaEvp&Pres, Merck Animal Heallth Sell 4,945 $130.23 $644K +7.1% —
Aug 10SEC Richard R. DelucaEvp&Pres, Merck Animal Heallth Sell 805 $131.02 $105K +6.5% —
Aug 10SEC Richard R. DelucaEvp&Pres, Merck Animal Heallth Sell 300 $131.02 $39K +6.5% —
Aug 7SEC David Michael WilliamsEvp,Chief Info&Digital Officer Sell 34,705 $128.77 $4.5M +8.4% —
Aug 7SEC Chirfi GuindoEvp, Access, Policy & Comms Sell 15,000 $131.00 $2.0M +6.5% —
Aug 7SEC David Michael WilliamsEvp,Chief Info&Digital Officer Sell 13,542 $128.77 $1.7M +8.4% —
Aug 7SEC David R. MaraldoEvp & Pres. Mmd Sell 9,709 $128.72 $1.2M +8.4% —
Aug 7SEC David R. MaraldoEvp & Pres. Mmd Sell 6,311 $128.72 $812K +8.4% —
Aug 7SEC David Michael WilliamsEvp,Chief Info&Digital Officer Sell 4,600 $128.77 $592K +8.4% —
Aug 7SEC David R. MaraldoEvp & Pres. Mmd Sell 2,686 $128.72 $346K +8.4% —
Feb 12SEC Chirfi GuindoChief Marketing Officer Sell 10,000 $121.46 $1.2M +14.9% —
Feb 10SEC Dean Y LiPresident Sell 10,235 $117.52 $1.2M +18.7% —
Feb 9SEC Jennifer ZacharyGeneral Counsel Sell 56,792 $119.15 $6.8M +17.1% —
Feb 9SEC Jennifer ZacharyGeneral Counsel Sell 38,835 $119.15 $4.6M +17.1% —
Feb 9SEC Jennifer ZacharyGeneral Counsel Sell 25,946 $119.15 $3.1M +17.1% —
Feb 9SEC Chirfi GuindoChief Marketing Officer Sell 10,000 $118.41 $1.2M +17.8% —
Feb 6SEC Caroline LitchfieldCFO Sell 41,997 $119.61 $5.0M +16.7% —
Feb 6SEC Richard R. DelucaEvp&Pres, Merck Animal Heallth Sell 37,685 $120.92 $4.6M +15.4% —
Feb 6SEC Robert M DavisCEO, President Sell 32,462 $118.35 $3.8M +17.9% —
Feb 6SEC Chirfi GuindoChief Marketing Officer Sell 20,000 $121.88 $2.4M +14.5% —
Feb 6SEC Johannes Jacobus OosthuizenPresident Sell 15,000 $121.87 $1.8M +14.5% —
Feb 6SEC Dean Y LiPresident Sell 15,087 $118.77 $1.8M +17.5% —
Feb 6SEC Robert M DavisCEO, President Sell 14,972 $117.38 $1.8M +18.9% —
Feb 6SEC David Michael WilliamsEvp,Chief Info&Digital Officer Sell 5,000 $121.91 $610K +14.5% —
Feb 6SEC Dalton E. Smart IIISvp Fin. - Global Controller Sell 4,000 $119.67 $479K +16.6% —
Feb 6SEC Dalton E. Smart IIISvp Fin. - Global Controller Sell 2,400 $119.67 $287K +16.6% —
Nov 12SEC Cristal N DowningChief Comm. & Public Afrs Ofcr Sell 7,085 $87.00 $616K +60.4% —
Nov 4SEC David Michael WilliamsEvp,Chief Info&Digital Officer Sell 8,614 $83.59 $720K +66.9% —

Insiders at Merck & Co.

InsiderBoughtSoldLast filingScore
Jennifer ZacharyGeneral Counsel — $25.2M Aug 13, 2026 —
Richard R. DelucaEvp&Pres, Merck Animal Heallth — $11.3M Aug 12, 2026 —
Chirfi GuindoEvp, Access, Policy & Comms — $8.2M Aug 13, 2026 —
David Michael WilliamsEvp,Chief Info&Digital Officer — $8.1M Aug 7, 2026 —
Robert M DavisCEO, President — $5.6M May 1, 2026 —
Caroline LitchfieldCFO — $5.0M May 1, 2026 —
Dean Y LiPresident — $3.0M May 1, 2026 —
David R. MaraldoEvp & Pres. Mmd — $2.4M Aug 7, 2026 —
Johannes Jacobus OosthuizenEvp, Oncology & Int?L — $1.8M May 1, 2026 —
Dalton E. Smart IIISvp Fin. - Global Controller — $766K May 5, 2026 —
Cristal N DowningChief Comm. & Public Afrs Ofcr — $616K Nov 12, 2025 —
Betty D LarsonEvp, Chief Hr Officer — — May 1, 2026 —
Sanat ChattopadhyayExe V-P & Pres. Mmd — — May 1, 2026 —
Joseph RomanelliPresident — — Jan 28, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • BSXBoston Scientific$9.5M bought
  • PFEPfizer$3.0M bought
  • COOCooper Companies (The)$1.9M bought
  • ELVElevance Health$1.4M bought
  • PODDInsulet Corporation$162K bought
  • SYKStryker Corporation$27K bought

Common questions about MRK insiders

Are Merck & Co. insiders buying MRK stock?

In the past 12 months, 0 insiders reported open-market purchases of MRK worth $0.

Are Merck & Co. insiders selling MRK stock?

11 insiders reported sales worth $72.0M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.